The artificial blood substitutes market which was USD 5.6 billion in 2021, is expected to reach USD 24.08 billion by 2029, at a CAGR of 20% during the forecast period 2022 to 2029.
Market Scope and Size- Artificial Blood Substitutes Market:
The artificial blood substitutes market is segmented on the basis of product type, source, application and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product Type
· Perfluorocarbon (PFCs)
· Haemoglobin-Based Oxygen Carries (HBOCs)
· Ox globin
· Hem pure
Source
· Human Blood
· Animal Blood
· Microorganism Based Recombinant HB
· Synthetic Polymers and Stem Cells
Application
· Cardiovascular Diseases
· Malignant Neoplasm
· Injuries
· Neonatal Conditions
· Organ Transplant and Maternal Condition
End User
· Hospital and Clinics
· Blood Banks
Get sample reports on:
Market Analysis and Insight- Artificial Blood Substitutes Market:
Artificial blood is used for restoring oxygen delivery after loss of blood from trauma, especially in emergency and battlefield situations, preventing the need for blood transfusions during surgery. It is a substitute blood product that can perform blood's most important function, which is the transport of oxygen and carbon dioxide. Artificial blood could be a life-saving measure, particularly in times of severe blood loss during large disasters; however, the products currently in development are incapable of performing secondary functions of blood, such as fighting infections.
Country Level Analysis- Artificial Blood Substitutes Market:
The countries covered in the artificial blood substitutes market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Key Players- Artificial Blood Substitutes Market:
Some of the major players operating in the artificial blood substitutes market are:
· Arum Biosciences (U.K.)
· HEMARINA (France)
· Haemoglobin Oxygen Therapeutics LLC (U.S.)
· Acolyte Inc. (U.S.)
· SpheriTech Ltd. (U.K.)
· Centrum Medicine Disused (Poland)
· European Medicines Agency (Netherlands)
· OPK Biotech Inc. (U.S.)
· Novo Pharma (U.S.)
· Prolong Pharmaceuticals, LLC
· Boston Pharmaceuticals (U.S.)
· OXYVITA Inc. (U.S.)
· Nano Blood LLC (U.S.)
Get Full Access of Report:
https://www.databridgemarketresearch.com/reports/global-artificial-blood-substitutes-market
MAJOR TOC OF THE REPORT:
· Chapter One: Introduction
· Chapter Two: Market Segmentation
· Chapter Three: Market Overview
· Chapter Four: Executive Summary
· Chapter Five: Premium Insights
· Chapter Six: Global Market by Product & Procedure type
Get TOC of Report:
https://www.databridgemarketresearch.com/toc/?dbmr=global-artificial-blood-substitutes-market
Browse Related Reports:
Global Medical Cannabis Based Oil Extract-Infused Products Market
Global Pet Cancer Therapeutics Market
Global Cold Compression Therapy Market
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market.
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sopan.gedam@databridgemarketresearch.com
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek